COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Chew Chee Lim

Dr. Chee Lim

Scientific Review Officer


Division of Translational and Clinical Sciences DTCS
Cardiovascular and Respiratory Sciences CVRS
Study Section:
Clinical and Integrative Cardiovascular Sciences CICS

Dr. Chee Chew Lim received his Ph.D. in physiology and then did his postdoctoral training in age-associated diastolic dysfunction at Boston University School of Medicine. Before joining the NIH, Dr. Lim was faculty at Vanderbilt University Medical Center, where he was an NIH-funded principal investigator studying the mechanisms that regulate and maintain the structural integrity of cardiac muscle sarcomeres. He also received pharmaceutical industry funding to investigate the potential cardiotoxic effects of a novel class of anticancer drugs, the proteasome inhibitors. He was Director of the Cardiovascular Pathophysiology and Complications Core at the NIH-funded Vanderbilt Mouse Metabolic Phenotyping Center. He also served as Course Director in Molecular Medicine in the Master of Science in Clinical Investigation Program at Vanderbilt University that taught core skills and methods in clinical and translational research.